Purpose: To detect the effect of various types of COVID-19 vaccine on macular and optic disc microvasculature.
Method: One hundred subjects receiving various types of COVID-19 vaccine (AstraZeneca, Sinopharm, Sinovac, Pfizer, and Moderna) were included in this study. A complete ophthalmic examination was done which included best-corrected visual acuity measurement, slit-lamp biomicroscopy, intraocular pressure measurement with Goldmann applanation tonometry, and fundus examination. Optical coherence tomography angiography (OCT-A) was done before and 1 week after receiving the vaccine. Superficial and deep macular capillary densities were measured in the form of the whole image, fovea, parafoveal, and perifoveal capillary density. Optic disc vessel density in the form of the whole disc, inside disc, and peripapillary were also measured.
Results: The superficial macular vessel densities, (whole image, fovea, parafoveal, and perifoveal) showed statistically non-significant changes with P-values (0.269, 0.167, 0.346, and 0.476) respectively. Also, the deep macular vessel densities showed statistically non-significant changes with P-values (0.491, 0.096, 0.724, and 0.386) for the whole image, fovea, parafoveal, and perifoveal respectively. Moreover, RPC (radial peripapillary capillary) density showed no significant changes either (the whole disc, inside disc, or peripapillary) with P-values (0.807, 0.141, 0.883) respectively.
Conclusion: Various types of COVID-19 vaccines had no statistically significant effects on macular or optic disc microvasculature.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827733 | PMC |
http://dx.doi.org/10.1016/j.pdpdt.2023.103275 | DOI Listing |
Front Digit Health
December 2024
MOH Office for Healthcare Transformation, Singapore, Singapore.
The COVID-19 pandemic in Singapore led to limited access to mental health services, resulting in increased distress among the population. This study explores the potential benefits of offering a digital mental health intervention (DMHI), Wysa, as a brief and longitudinal intervention as part of the mindline.sg initiative launched by the MOH Office for Healthcare Transformation in Singapore.
View Article and Find Full Text PDFPrisons have been hotspots for COVID-19 and likely an important driver of racial disparity in disease burden. From the first COVID-19 case detected through March 25, 2022, 66,684 of 196,652 residents of California's state prison system were infected, most of them in two large winter waves of outbreaks that reached all 35 of the state prisons. We used individual-level data on disease timing and nightly room assignments in these prisons to reconstruct locations and pathways of transmission statistically, and from that estimated reproduction numbers, locations of unobserved infection events, and the subsequent magnitude and distribution of long COVID prevalence.
View Article and Find Full Text PDFActa Otorhinolaryngol Ital
December 2024
Audiology and Phoniatrics Service, ENT Department, University of Modena e Reggio Emilia, Modena, Italy.
Objectives: The SARS-CoV-2 pandemic required the use of personal protective equipment (PPE) in medical and social contexts to reduce exposure and prevent pathogen transmission. This study aims to analyse possible changes in voice and speech parameters with and without PPE.
Methods: Speech samples using different types of PPE were obtained.
Iran J Nurs Midwifery Res
November 2024
Health Information Technology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Background: The purpose of this scoping review is to identify the models of Health Information Disorders (HIDs), the components of these models, their study setting, and their designing approaches.
Materials And Methods: In this study, PubMed, Web Of Science (WOS), Scopus, ProQuest, and Embase databases were searched to identify relevant articles. After screening the identified studies, 22 studies were selected.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!